Entero Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ENTO and buy or sell other stocks, ETFs, and their options commission-free!About ENTO
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
CEOJason D. Sawyer
CEOJason D. Sawyer
Employees2
Employees2
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2014
Founded2014
Employees2
Employees2
ENTO Key Statistics
Market cap12.18M
Market cap12.18M
Price-Earnings ratio-0.25
Price-Earnings ratio-0.25
Dividend yield—
Dividend yield—
Average volume157.86K
Average volume157.86K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.84
52 Week high$5.84
52 Week low$0.9693
52 Week low$0.9693
Stock Snapshot
The current Entero Therapeutics(ENTO) stock price is $4.78, with a market capitalization of 12.18M. The stock trades at a price-to-earnings (P/E) ratio of -0.25.
During the trading day, Entero Therapeutics(ENTO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 157.86K.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
People also own
Based on the portfolios of people who own ENTO. This list is generated using Robinhood data, and it’s not a recommendation.